This page shows you your search results in order of relevance. This is page number 9.

Order by Relevance | Date

Total 442 results found since Jan 2013.

Hemostasis Solution Controls Bleeding during Surgery
A novel handheld device delivers a powder based on collagen to help surgeons achieve hemostatic bleeding control during surgical procedures.The Biom ’Up (Saint-Priest, France) HemoBlast Bellows is a sterile delivery device that is preloaded with a dry, sterile powder made of highly purified porcine collagen, glucose, chondroitin sulfate, and thrombin. The hemostatic powder is applied to the source of the bleeding by squeezing the bellows. Once applied, the powdered collagen and glucose components start the coagulation process by absorbing blood, concentrating coagulation factors and platelets, and providing a surface for...
Source: Medical Hemostat - January 2, 2018 Category: Medical Devices Authors: hemostatguy at gmail.com (hemostat guy) Source Type: blogs

SURGICEL & #194; & #174; Powder Absorbable Hemostat is used in surgeries.
SURGICEL® Powder Absorbable Hemostat is used for broad-surface oozing and stops bleeding fast. Unit is suitable for gynecologic, oncologic, cardiovascular and general procedure applications. Product offers bactericidal activity in vitro against MRSA, MRSE, VRE, PRSP, E Coli pathogens.This story is related to the following:Hemostats
Source: Industrial Newsroom - Health, Medical and Dental Supplies - January 10, 2018 Category: Medical Devices Source Type: news

Axiostat is India ’ s first entry on the U.S. hemostat market
Indian medical device maker Axio Biosolutions became the first Indian company with a wound care product cleared by the FDA, according to a press release from the company posted yesterday. The federal watchdog granted 510(k) clearance to Axio’s Axiostat chitosan hemostatic dressing, which is cleared as an over-the-counter product to stop external bleeding. The dressing is designed to stop uncontrollable bleeding within two to three minutes of application, and is used by the Indian armed forces, the company said. “The FDA clearance of Axiostat in the US is a major milestone in our journey so far. This is a valida...
Source: Mass Device - March 1, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Blood Management Regulatory/Compliance Wound Care axiobiosolutions Source Type: news

Cohera Medical Inc. ® Awarded Patent on its Biodegradable Sealant Technology
Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that the U.S. Patent and Trademark Office (USPTO) has issued the Company a notice of allowance on its patent application, titled “SILANE-CONTAINING MOISTURE-CURABLE TISSUE SEALANT”.The patent relates to a novel 100% synthetic sealant with several potential surgical applications.  The sealant covered by the patent, Sylys ® Surgical Sealant, is highly elastic, and has good bonding strength to internal tissues.  In addition, the sealant is easy to prepare and apply in the operating theatre and ...
Source: Medical Hemostat - April 25, 2018 Category: Medical Devices Authors: hemostatguy at gmail.com (hemostat guy) Source Type: blogs

GRGDS-functionalized chitosan nanoparticles as a potential intravenous hemostat for traumatic hemorrhage control in an animal model
Publication date: Available online 5 September 2018Source: Nanomedicine: Nanotechnology, Biology and MedicineAuthor(s): Pingyi Zhang, Subo Li, Shikun Zhang, Xue Zhang, Luming Wan, Zhimin Yun, Shouping Ji, Feng Gong, Manna Huang, Leilei Wang, Xinhai Zhu, Yingxia Tan, Yiqian WanAbstractHemostats, which are used for immediate intervention during internal hemorrhage in order to reduce resulting mortality and morbidity, are relatively rare. Here, we describe novel intravenous nanoparticles (CPG-NPs-2000) with chitosan succinate (CSS) as cores, polyethylene glycol (PEG-2000) as spacers and a glycine-arginine-glycine-aspartic aci...
Source: Nanomedicine: Nanotechnology, Biology and Medicine - September 5, 2018 Category: Nanotechnology Source Type: research

FDA permits marketing of new endoscopic device for treating gastrointestinal bleeding
The U.S. Food and Drug Administration permitted marketing of Hemospray, a new device used to help control certain types of bleeding in the gastrointestinal (GI) tract.“The device provides an additional, non-surgical option for treating upper and lower GI bleeding in certain patients, and may help reduce the risk of death from a GI bleed for many patients,” said Binita Ashar, M.D., director, division of surgical devices, in the FDA’s Center for Devices and R adiological Health.GI bleeding can occur in the upper GI tract (esophagus, stomach or small intestine) or the lower GI tract (colon and rectum). Causes of GI blee...
Source: Medical Hemostat - September 23, 2018 Category: Medical Devices Authors: hemostatguy at gmail.com (hemostat guy) Source Type: blogs

Experimental Evaluation of a New Tissue Factor-Based Topical Hemostat (TT-173) for Treatment of Hepatic Bleeding.
CONCLUSIONS: TT-173 shows favorable pharmacodynamic properties for improving hemostasis in partial liver resection which support further investigation of the product in this surgical indication. PMID: 30380352 [PubMed - as supplied by publisher]
Source: Journal of Investigative Surgery - November 2, 2018 Category: Surgery Tags: J Invest Surg Source Type: research

Investigation of efficiency of a novel, zinc oxide loaded TEMPO-oxidized cellulose nanofiber based hemostat for topical bleeding.
Abstract Lethal bleeding due to street accidents, natural calamities, orthopedic/dental surgeries, organ transplantation and household injuries, is the leading cause of morbidity and mortality. In the current study, zinc oxide (ZnO) was incorporated in TEMPO-oxidized cellulose nanofiber (TOCN) and polyethylene glycol (PEG) polymer system for hemorrhage control by freeze drying method. SEM and XRD data showed the presence of ZnO in the porous structure. FT-IR analysis showed that, successful conjugation occurs among the TOCN and PEG. The results revealed that, the incorporation of ZnO and higher concentrations of P...
Source: International Journal of Biological Macromolecules - December 8, 2018 Category: Biochemistry Authors: Shefa AA, Taz M, Hossain M, Kim YS, Lee SY, Lee BT Tags: Int J Biol Macromol Source Type: research

Advanced Medical Solutions Group plc: Acquisition of Sealantis
Winsford, UK, 31 January 2019: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, today announces it has acquired Sealantis Limited ( “Sealantis”), a developer of an alginate-based tissue adhesive technology platform, for $US 25m (approximately £19m) in cash with royalties due until December 2027 on sales of any of its products that are currently in development.Overview of SealantisSealantis is an Israeli-based medical device company with a patent-protected alga-mimetic sealants technology platform with a wide range of potential surgical indications under developm...
Source: Medical Hemostat - February 1, 2019 Category: Medical Devices Authors: hemostatguy at gmail.com (hemostat guy) Source Type: blogs

Lymphostasis and Hemostasis in Body-Contouring Surgery Using a Polysaccharide Based Hemostat (4DryField PH)
Conclusions: This is the first prospective, monocentric, randomized study on 4DF in body-contouring surgery. The use of 4DF did not lead to a better postoperative outcome regarding hemostasis and lymphostasis. Potential benefits need further evaluation in high-volume studies.
Source: Plastic and Reconstructive Surgery Global Open - March 1, 2019 Category: Cosmetic Surgery Tags: Original Article Source Type: research

Application techniques of a novel hemostat in cardiac operations: HEMOBLAST
ConclusionHB is a novel powder ‐based multiple component hemostatic agent that promotes focal or large area hemostasis. We have presented the techniques of use that are important to the successful application of HB to facilitate hemostasis.
Source: Journal of Cardiac Surgery - July 25, 2019 Category: Cardiovascular & Thoracic Surgery Authors: Brian A. Bruckner, Uy Ngo, Mahesh Ramchandani, Erik Suarez, Samir Awad, Michael Reardon Tags: SURGICAL TECHNIQUE Source Type: research

Anti-infective and wound-healing pleiotropic actions of Ankaferd hemostat.
Authors: Haznedaroğlu IC, Çelebier M Abstract no needed for the letter to the editor. PMID: 32305048 [PubMed - as supplied by publisher]
Source: Turkish Journal of Medical Sciences - April 21, 2020 Category: General Medicine Tags: Turk J Med Sci Source Type: research

Association between intraoperative application of microfibrillar collagen hemostat and anastomotic leakage after anterior resection for rectal cancer: A retrospective case-control study
The purpose of the study is to evaluate the association between microfibrillar collagen hemostat and anastomotic leakage after anterior resection.
Source: Surgery - November 4, 2020 Category: Surgery Authors: Meng Kong, Hongyuan Chen, Yugang Jiang, Yingying Xin, Yue Han, Hongguang Sheng Source Type: research

Hemostatic Efficacy and Biocompatibility Evaluation of a Novel Absorbable Porous Starch Hemostat
CONCLUSION: According to our study, Ca2+CPSM could effectively achieve hemostasis in the standard rat liver injury model and exhibited good blood compatibility and in vivo tissue compatibility. These finding suggested that Ca2+CPSM as a new kind of APSH had its extensive clinical application value.PMID:34551638 | DOI:10.1177/15533506211046100
Source: Surgical Innovation - September 23, 2021 Category: Surgery Authors: Jianjun Zhu Zhuona Wu Wenzhong Sun Zhiyun Meng Xiaoxia Zhu Hui Gan Ruolan Gu Xuan Guo Guifang Dou Source Type: research